Company: LIDRW
Filing Date: 2025-01-16
Form Type: S-1
Source: 0000947871-25-000056
Chunk: 37

Company: AEye, Inc.
Filing Date: 2025-01-16
Form: S-1
Chunk 37
---
(a)(2) of the Securities Act.

| 31 |

The Tumim Stone Transaction

On December 8, 2021, we completed a private placement to Tumim Stone, pursuant
to which we have the right to sell to Tumim Stone up to $125 million in shares of our Common Stock, subject to certain limitations, from
time to time over the approximate 36-month period commencing on the closing date of the common stock purchase agreement dated December
8, 2021, provided that the conditions precedent to Commencement have occurred. We issued 10,088 shares of our Common Stock as commitment
shares to Tumim Stone as consideration for its irrevocable commitment to purchase our shares under the Purchase Agreement.

The securities were issued or sold by us under the Purchase Agreement in
reliance upon an exemption from the registration requirements under the Securities Act of 1933, or the Securities Act, afforded
by Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated thereunder. In the Purchase
Agreement, Tumim Stone represented to us, among other things, that it was an “accredited investor” (as such term is defined
in Rule 501(a) of Regulation D under the Securities Act).

The September 2022 Transaction

On September 15, 2022, the Company entered into a Securities Purchase Agreement
in connection with a transaction pursuant to which the Company issued to an institutional investor, a senior unsecured convertible promissory
note and a warrant to purchase the Company’s Common Stock. The offer, sale and issuance of the note and the warrant was made in
reliance upon the exemptions contained in Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation
D promulgated thereunder. The Note Registration Rights Agreement requires the Company to prepare and file a registration statement
to cover the resale of the Company’s Common Stock issuable upon conversion of the note and/or exercise of the warrant. Such registration
statement on Form S-3 (Registration No. 333-267937) was filed by the Company with the SEC under the Securities Act on October
19, 2023, and declared effective by the SEC on October 27, 2023.

Dowslake Transaction

On May 10, 2024, the Company entered into the Dowslake Purchase Agreement with Dowslake, pursuant to which Dow